drugset / Trial / NCT00425451

The Efficacy and Safety of PerioChip Plus (Flurbiprofen/Chlorhexidine) Formulation in the Therapy of Adult Periodontitis

NCT00425451

Phase 2 Completed 80 enrolled Dexcel Pharma Technologies Ltd.
RandomizedParallel-groupDouble-blindTreatment

Summary

The purpose of this study is to determine the effect of the placement of a PerioChip Plus (flurbiprofen/chlorhexidine - FBP/CHX) formulation versus PerioChip (chlorhexidine) formulation versus Flurbiprofen Chip formulation versus Placebo Chip formulation on probing pocket depth (PPD)

Timeline

Start
2008-08
Primary completion
2009-01
Completion
2009-03

Drugs

EvaluationDrugModalityDoseRoute
Subject Chlorhexidine Small molecule
Subject Flurbiprofen Small molecule

Indications